vimarsana.com

Latest Breaking News On - Biocon limited - Page 1 : vimarsana.com

Equillium to Present at the Jefferies Global Healthcare Conference

Equillium, Inc. , a clinical-stage biotechnology company focused on developing novel therapeutics to treat severe autoimmune and inflammatory disorders, today announced that it will present at the.

Biocon signs exclusive licensing deal for comercialisation of obesity drug in South Korea

Biocon signs exclusive licensing deal for comercialisation of obesity drug in South Korea
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

Biocon signs licensing deal with Handok in South Korea - The Hindu BusinessLine

Biocon Limited partners with Handok Inc. for exclusive licensing of Synthetic Liraglutide in South Korea, targeting weight management market.

Biocon to invest ₹2,200 crore in capex in the next 2 years - The Hindu BusinessLine

Biocon Limited's Q4 FY24 results show a 56.7% profit decline, CEO discusses performance and future roadmaps with BusinessLine.

Dr Kiran Mazumdar-Shaw inaugurates bio sciences lab at Chanakya University, Bengaluru

Dr Kiran Mazumdar-Shaw inaugurates bio sciences lab at Chanakya University, Bengaluru
biospectrumindia.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biospectrumindia.com Daily Mail and Mail on Sunday newspapers.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.